Zheng, Lixin
Zheng, Lixin was paid $406K by Medicaid between Jan 2018 and Dec 2024, across 5 billing codes. Its largest line is 92004, Ophthalmological services: medical examination and evaluation, comprehensive, new patient — 44% of everything it billed.
33Billing provider infoZHENG, LIXIN
BELMONT, MA 02478
BELMONT, MA 02478
33aNPI1053753475assigned 07/26/2013
33bProvider typeOptometrist
28Total paid$406K
24GClaims11,420
24DCodes billed5
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Optometrist providers in Massachusetts
Rank by total paid#52 of 629
Median peer was paid$15K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,606 | $57K | |
| 2019 | 1,849 | $64K | |
| 2020 | 1,246 | $44K | |
| 2021 | 1,684 | $59K | |
| 2022 | 1,650 | $59K | |
| 2023 | 1,766 | $64K | |
| 2024incomplete | 1,619 | $60K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 44% | 2,603 | 2,602 | $180K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 36% | 2,887 | 2,885 | $147K |
| 92015 | Determination of refractive state | 18% | 5,667 | 5,667 | $72K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1.8% | 249 | 209 | $7K |
| V2020 | Frames, purchases | <1% | 14 | 14 | $106.25 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.